BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33178581)

  • 1. Ten-Year Outcomes of Percutaneous Radiofrequency Ablation for Colorectal Cancer Liver Metastases in Perivascular vs. Non-Perivascular Locations: A Propensity-Score Matched Study.
    Jiang B; Luo H; Yan K; Zhang Z; Li X; Wu W; Yang W; Chen M
    Front Oncol; 2020; 10():553556. PubMed ID: 33178581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
    Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
    Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival.
    Akhan O; Akçalar S; Ünal E; Metin Y; Çiftçi T; Akıncı D
    Turk J Gastroenterol; 2023 Jun; 34(6):645-651. PubMed ID: 37232461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes.
    Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
    Radiology; 2014 Mar; 270(3):888-99. PubMed ID: 24475820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
    Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factors.
    Klubien J; Rosenberg J; Skjoldbye BO; Lorentzen T; Nolsøe CP; Pommergaard HL
    Ultrasonography; 2023 Jul; 42(3):410-420. PubMed ID: 37337360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ablation of colorectal liver metastases: a comparison between the outcomes of grayscale US guidance and Sonazoid CEUS Kupffer phase guidance using propensity score matching.
    Qin S; Zhou J; Cui R; Chen Y; Wang Y; Liu G
    Int J Hyperthermia; 2023; 40(1):2260573. PubMed ID: 37788806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
    Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
    Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38041717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural risk factors for incomplete radiofrequency ablation of liver metastases from colorectal cancer: a single-center retrospective analysis.
    Fan H; Wang X; Qu J; Lu W; Pang Z; Shao T; Xia J; Wang H; Li G; Zhang Y; Sun J; Yang X
    Int J Hyperthermia; 2021; 38(1):985-994. PubMed ID: 34167430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?
    Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J
    Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
    Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
    Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer.
    Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT
    Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
    Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
    Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.